CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.

MLA

Caby, Fabienne, et al. “CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 73, no. 1, July 2021, pp. 50–59. EBSCOhost, https://doi.org/10.1093/cid/ciaa1137.

APA

Caby, F., Guiguet, M., Weiss, L., Winston, A., Miro, J. M., Konopnicki, D., Le Moing, V., Bonnet, F., Reiss, P., Mussini, C., Poizot-Martin, I., Taylor, N., Skoutelis, A., Meyer, L., Goujard, C., Bartmeyer, B., Boesecke, C., Antinori, A., Quiros-Roldan, E., … Grabar, S. (2021). CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 73(1), 50–59. https://doi.org/10.1093/cid/ciaa1137

Chicago

Caby, Fabienne, Marguerite Guiguet, Laurence Weiss, Alan Winston, Jose M Miro, Deborah Konopnicki, Vincent Le Moing, et al. 2021. “CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 73 (1): 50–59. doi:10.1093/cid/ciaa1137.